-
Board considering access to BELOB RNA-seq data
Dac
EGAC00001001686
-
DAC related to monozygotic twins discordant for ALS
Dac
EGAC00001003524
-
Defining and Overcoming Intrinsic T Cell Dysfunction to Enable Pediatric Immunotherapy
Study
phs002323
-
Sensitivity to the Subjective Effects of Amphetamine
Study
phs000832
-
Germline Aberrations of PAX5 Cause Susceptibility to pre-B cell Acute Lymphoblastic Leukemia
Study
EGAS00001000447
-
Genome-wide expression profiles to compare array-based, RNAseq and NanoString technologies in patients with resected pancreatic ductal carcinoma.
Study
EGAS00001002501
-
Patient-derived organoids as a novel tool to study cervical cancer
Study
EGAS00001004439
-
Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor
Study
EGAS00001004899
-
Pediatric CNS tumor classification by DNA-methylation dataset
Dataset
EGAD00010002599
-
Exceptional Outcomes in a Phase Ib Study Combining PARP and MEK Inhibition, With or Without Anti-PD-L1, for BRCA-Wildtype Platinum-Sensitive Recurrent Ovarian Cancer
Study
EGAS00001007496